Peer Review History
| Original SubmissionJanuary 12, 2026 |
|---|
|
Dear Dr. Chowdhury, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 11 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Syeda Humaida Hasan, Diploma in Child Health, FCPS (Pediatrics) Academic Editor PLOS One Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 3. We note that there is identifying data in the Supporting Information file < S1 File.xlsx>. Due to the inclusion of these potentially identifying data, we have removed this file from your file inventory. Prior to sharing human research participant data, authors should consult with an ethics committee to ensure data are shared in accordance with participant consent and all applicable local laws. Data sharing should never compromise participant privacy. It is therefore not appropriate to publicly share personally identifiable data on human research participants. The following are examples of data that should not be shared: -Name, initials, physical address -Ages more specific than whole numbers -Internet protocol (IP) address -Specific dates (birth dates, death dates, examination dates, etc.) -Contact information such as phone number or email address -Location data -ID numbers that seem specific (long numbers, include initials, titled “Hospital ID”) rather than random (small numbers in numerical order) Data that are not directly identifying may also be inappropriate to share, as in combination they can become identifying. For example, data collected from a small group of participants, vulnerable populations, or private groups should not be shared if they involve indirect identifiers (such as sex, ethnicity, location, etc.) that may risk the identification of study participants. Additional guidance on preparing raw data for publication can be found in our Data Policy (https://journals.plos.org/plosone/s/data-availability#loc-human-research-participant-data-and-other-sensitive-data) and in the following article: http://www.bmj.com/content/340/bmj.c181.long. Please remove or anonymize all personal information (<specific identifying information in file to be removed>), ensure that the data shared are in accordance with participant consent, and re-upload a fully anonymized data set. Please note that spreadsheet columns with personal information must be removed and not hidden as all hidden columns will appear in the published file. 4. We notice that your supplementary figure is uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: The purpose of this study was to assess the prevalence of nomophobia among Bangladeshi medical and university students as well as look into the sociodemographic characteristics and smartphone-related behaviours that are linked to it. My observations are given below: (1) The study title is okay. (2) The abstract needs minor revision. It is thorough and up to date, with precise goals and suitable techniques. Enhance concision, provide justification for a longer data collection period, elucidate the sampling strategy, report effect sizes, temper causal language given the cross-sectional design, and contextualize the findings within Bangladesh. (3) The introduction gives a general overview of nomophobia and references a lot of research, but it needs a lot of work. Prevalence statistics and definitions are occasionally out-of-date or geographically misaligned, and the justification for Bangladesh's focus seems dated and poorly thought out. Numerous sentences are repetitive, too detailed, or only loosely related. Citations should not be listed; instead, they should be condensed and critically synthesized. The theoretical framework lacks clarity, and the main research gaps are not stated clearly. The introduction would be strengthened by making concepts clearer, tightening the structure, and enhancing coherence. (4) Although the methodology is generally clear, there are a few issues that need to be addressed. It should be noted that selection bias may be introduced and generalizability may be limited by snowball sampling and online data collection. For a cross-sectional design, the two-year data collection window is excessively long and requires explanation. There are reported conflicting NMP-Q cut-off classifications that need to be resolved. Regression, ANOVA, and t-test assumptions are not specified. Clarification is needed regarding the operational definitions of independent variables and how to handle missing data. There is no power analysis or sample size calculation. (5) With thorough descriptive statistics and appropriate use of bivariate and multivariate analyses, the results are thorough and presented in an understandable manner. Nevertheless, the sample size reporting is inconsistent (n=476 vs. n=436) that need to be clarified. There are apparent typographical errors in certain tables (e.g. frequencies of the academic year). It would improve interpretation if effect sizes were reported in addition to p-values. Think about eliminating unnecessary repetition in the text and tables and providing clear justification for the covariates used in regression models. Additionally, to further improve methodological transparency, assumptions testing and handling missing data should be reported. (6) The thorough and properly referenced discussion successfully places the findings in both regional and global literature. But instead of providing a more thorough theoretical interpretation, it is repetitive and unduly descriptive, frequently restating the findings. Age and gender comparisons are erratic and require more precise synthesis. The conclusion could be shorter and more focused on prevention or intervention implications rather than generalizations. A greater focus should be placed on the limitations of sampling and the use of self-report. (7) The references are okay. Please correct it by following the journal’s guidelines. The tables and figures should be prepared following standard guidelines. Reviewer #2: Based on the title, there are differences between medical students and other academic specializations, but there are no clear indications of these differences in the paper's results or discussion; the authors failed to use this particularity statistically. It is appropriate to use this type of regression analysis with this data, but the authors did not specify whether the 'normality of residuals' or 'homoscedasticity' were tested, both of which are essential for the validity of linear regression results. The absence of the coefficient of determination (R²) means the overall 'power of the model' was not provided; its absence leaves us uncertain whether the model explains only 10% or 70% of the problem. Additionally, the paper included 'age' in the model despite its very weak correlation (r=0.12). Some of these variables could have been considered mediating variables (e.g., social media applications, daily usage hours), and mediation analysis could have been used to interpret the results more accurately. Writing all demographic and descriptive data in a long textual format makes it merely a textual account of the numbers. Furthermore, the tables need formatting as they contain too much information. In lines (168-179), the researcher used complex and repetitive technical language. An introductory paragraph could have been written saying: 'After adjusting for demographic variables (gender, income, etc.), the results showed the following... The discussion section exaggerates the statistical comparison between the study's results and other papers without providing a clear benefit for discussing the findings. For instance, the authors did not provide any explanation in the discussion for why females are more prone to nomophobia. In a nutshell, nomophobia is a pressing issue in today’s world. In this modern era, avoiding smartphones and devices is nearly impossible as we are heavily dependent on them in our day-to-day activities. Therefore, it is crucial to raise awareness of the negative impacts of nomophobia and conduct extensive research on it. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Gyanesh Kumar Tiwari Reviewer #2: Yes: Mahmud Hamakareem Mahmud ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
PLOS One Dear Dr. Chowdhury, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== 1. Please check the punctuation mark and any grammatical error. 'Phone use upon waking, and extensive engagement with social communication and media applications are associated with excessive smartphone use and the development of nomophobia; however, causality cannot be inferred due to the cross-sectional study design.” The semicolon before “however” is missing and should be inserted. 2. Please avoid excessive multiple citations supporting a single statement in the introduction. In the sentence: Relevant text (“Although no notable gender differences were found in smartphone use, nomophobia scores between men and women showed remarkable deviation [14,17,18,20–24,26,30–32]”.) The large number of references should be reduced and only the most relevant and representative studies should be cited to improve readability and avoid citation clutter. 3. Please clarify the exclusion criteria. The manuscript states that students who did not own a mobile device were excluded. However, it is unclear whether this refers to students without any mobile phone or specifically those without smartphones. 4. The authors have not clearly stated whether the Nomophobia Questionnaire (NMP-Q) has been previously validated in the Bangladeshi population. The manuscript only mentions a pilot test. This issue should be addressed in the limitations section. The authors should also discuss the absence of formal psychometric validation (e.g., construct validity assessment) or provide additional validation analyses if available. [Relevant text:“Prior to the main study, the questionnaire underwent a pilot test among 60 participants to assess reliability using Cronbach’s alpha (α = 0.82).] 5. In line 207, please replace “higher nomophobia” with “higher nomophobia score” for clarity and scientific accuracy. 6.Several reported effect sizes (e.g., η² = 0.015) are marked. Please verify whether these have been correctly interpreted and whether they are statistically and practically meaningful. Ensure consistency in reporting and interpretation of effect sizes throughout the manuscript. 7. The statistical analysis section requires revision for consistency. The authors state that both multiple linear regression and logistic regression were used; however, the outcome variable (NMP-Q score) is continuous, and only multiple linear regression is presented in the results. No logistic regression analysis or corresponding results are provided in the manuscript. Therefore, the mention of logistic regression is misleading and should be removed or revised to accurately reflect the analysis performed. The authors should ensure that the statistical methods section is fully consistent with the reported analyses. Additionally, the description of regression assumption testing is overly detailed and should be streamlined to remove redundant wording. ============================== Please submit your revised manuscript by Aug 05 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Syeda Humaida Hasan, Diploma in Child Health, FCPS (Pediatrics) Academic Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: I thoroughly examined the updated manuscript and discovered that the authors had successfully incorporated the recommendations from the earlier review. It does not require further changes. Reviewer #2: I would like to thank the authors for their meticulous efforts in thoroughly addressing all my concerns in this revision. The statistical rigor has been significantly improved by properly testing the regression assumptions and including the R² value. Furthermore, the distinction between medical and non-medical specializations is now clear, and the data presentation has been streamlined beautifully. The discussion section provides meaningful, well-reasoned socio-behavioral explanations for the findings. The manuscript now fully meets the high standards of PLOS ONE. I recommend it for final acceptance. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Gyanesh Kumar Tiwari Reviewer #2: Yes: Mahmud Hamakareem Mahmud ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
PREVALENCE AND ASSOCIATED FACTORS OF NOMOPHOBIA AMONG THE MEDICAL AND UNIVERSITY STUDENTS OF BANGLADESH PONE-D-26-01093R2 Dear Dr. Chowdhury, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Syeda Humaida Hasan, Diploma in Child Health, FCPS (Pediatrics) Academic Editor PLOS One Additional Editor Comments (optional): Multiple citations for a single statement are also repeated in other sentences. Please check all references carefully to ensure they are cited appropriately and presented in the correct chronological order. Additionally, Reference 31 is missing. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-26-01093R2 PLOS One Dear Dr. Chowdhury, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS One and supporting open access. Kind regards, PLOS One Editorial Office Staff on behalf of Dr. Syeda Humaida Hasan Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .